GoalVest Advisory LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
GoalVest Advisory LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$11,849
-74.1%
32,915
-36.3%
0.01%
-76.7%
Q4 2022$45,753
-13.7%
51,640
+53.6%
0.03%
-18.9%
Q3 2022$53,00033,6150.04%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders